ARCHIVES

Volasertib and LDAC Doubled Response in Older Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Symptoms Don’t Help Detect Early-Stage Ovarian Cancer

February 26, 2010

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

In Brief: Weicker Heads New Group For More Spending On Medical Research; Committee Oks Sullivan

March 3, 1989